Medtronic Buys Into Arsenal, Gets Option to Purchase the Post-Surgical Foam Startup Subsidiary
Thursday, June 18, 2015
Medtronic ($MDT) has invested in a subsidiary of Arsenal Medical, a startup focused on developing a polymer-based foam to control intra-abdominal bleeding. The device giant gains an option to acquire the subsidiary, Arsenal AAA, upon the achievement of undisclosed milestones. Medtronic also didn't reveal how much it invested in the deal.